...
首页> 外文期刊>The Journal of heart valve disease >Successful catheter-based valve-in-valve implantation for a regurgitant stentless bioprosthesis.
【24h】

Successful catheter-based valve-in-valve implantation for a regurgitant stentless bioprosthesis.

机译:成功的基于导管的瓣膜内瓣膜植入术可用于无反流的无支架生物假体。

获取原文
获取原文并翻译 | 示例

摘要

Catheter-based transapical aortic valve implantation (TA-AVI) in patients with severe stenosis of the aortic valve and with a high operative risk is a new procedure which is becoming established in clinical practice. Aortic regurgitation is not yet a recognized indication for TA-AVI, and to date valve-in-valve (V-in-V) implantation in patients with incompetent stentless bioprostheses has not been attempted. The case is reported of a successful TA-AVI in a regurgitant, uncalcified stentless Medtronic Freestyle bioprosthesis. The position and hemodynamic function of the apically implanted valve were excellent, and the patient's current state of health is good.
机译:重度主动脉瓣狭窄且手术风险高的患者,以导管为基础的经心尖主动脉瓣植入术(TA-AVI)是一种新方法,正在临床实践中确立。主动脉瓣关闭不全尚未被公认是TA-AVI的适应症,迄今为止,尚未尝试将无瓣膜无生物假体患者的瓣膜内(V-in-V)植入。据报道,该病例在反流,未钙化的无支架美敦力Freestyle生物假体中成功使用了TA-AVI。根尖植入瓣膜的位置和血液动力学功能极佳,患者目前的健康状况良好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号